Market Tracker

04/17 6:05pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

13.46
Data as of Apr 17
 -0.46 / -3.30%
Today’s Change
6.61
Today|||52-Week Range
17.46
+3.94%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close13.92
Today’s open13.97
Day’s range13.43 - 14.17
Volume2,773,736
Average volume (3 months)3,239,878
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)+15.00%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book26.78

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.11+1.48%
NKTRNektar Therapeutics-0.07-0.68%
DYAXDyax Corp-0.07-1.03%
SGMOSangamo BioSciences ...-0.27-1.89%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 13, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts